Enanta Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.2M | 18.6M | 15.1M | 18.3M | 14.9M | 17.0M | 14.6M | 18.0M |
| Cost of Goods Sold | 1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 15.9M | 18.6M | 15.1M | 18.3M | 14.9M | 17.0M | 14.6M | 18.0M |
| R&D Expenses | 19.4M | 20.9M | 23.8M | 27.2M | 28.1M | 27.7M | 30.8M | 28.7M |
| Operating Expenses | 27.8M | 29.9M | 33.5M | 37.2M | 39.5M | 40.5M | 44.5M | 42.2M |
| Operating Income | -11.9M | -11.3M | -18.4M | -18.9M | -24.5M | -23.5M | -29.9M | -24.2M |
| Other Income / Gains | -1.2M | -661K | -282K | 667K | 578K | 837K | 668K | 1.1M |
| Net Income | -13.1M | -11.9M | -18.7M | -18.3M | -22.6M | -22.3M | -28.8M | -22.7M |
| EPS (Diluted) | -0.45 | -0.56 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.93 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 9.6M | 9.0M | 9.7M | 10.0M | 11.4M | 12.8M | 13.7M | 13.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 9.6M | 9.0M | 9.7M | 10.0M | 11.4M | 12.8M | 13.7M | 13.4M |
| Other Expenses | -1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 29.0M | 29.9M | 33.5M | 37.2M | 39.5M | 40.5M | 44.5M | 42.2M |
| Interest Income | 2.1M | 2.4M | 2.1M | 2.3M | 2.3M | 2.8M | 3.2M | 3.5M |
| Interest Expense | 3.3M | 3.1M | 2.4M | 1.6M | 1.7M | 2.0M | 2.6M | 2.4M |
| Depreciation And Amortization | 1.2M | 1.2M | 1.3M | 1.2M | 1.2M | 889K | 479K | 594K |
| Ebitda | -8.6M | -7.6M | -15.0M | -15.4M | -21.0M | -19.9M | -26.1M | -20.1M |
| Ebitdaratio | -0.499 | -0.408 | -0.992 | -0.841 | -1.409 | -1.171 | -1.789 | -1.119 |
| Operating Income Ratio | -0.691 | -0.605 | -1.216 | -1.032 | -1.643 | -1.388 | -2.044 | -1.346 |
| Income Before Tax | -13.1M | -11.9M | -18.7M | -18.2M | -23.9M | -22.7M | -29.2M | -23.1M |
| Income Before Tax Ratio | -0.763 | -0.64 | -1.234 | -0.995 | -1.605 | -1.339 | -1.998 | -1.283 |
| Income Tax Expense | 7K | 24K | 32K | 29K | -1.3M | -416K | -363K | -395K |
| Net Income Ratio | -0.763 | -0.641 | -1.236 | -0.997 | -1.517 | -1.314 | -1.973 | -1.261 |
| Epsdiluted | -0.45 | -0.56 | -0.87 | -0.86 | -1.06 | -1.05 | -1.36 | -1.07 |
| Weighted Average Shs Out | 21.4M | 21.4M | 21.4M | 21.3M | 21.4M | 21.2M | 21.2M | 21.2M |
| Weighted Average Shs Out Dil | 21.4M | 21.4M | 21.4M | 21.3M | 21.4M | 21.2M | 21.2M | 21.2M |